Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 31, Issue Suppl 3
40 InnovaTV 301/ENGOT-cx12/GOG-3057: tisotumab vedotin vs investigator’s choice chemo in second- or third-line recurrent or metastatic cervical cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Cervical cancer
40 InnovaTV 301/ENGOT-cx12/GOG-3057: tisotumab vedotin vs investigator’s choice chemo in second- or third-line recurrent or metastatic cervical cancer
Free
Online download statistics by month:
Online download statistics by month: October 2021 to March 2024
Abstract
Full
Pdf
Oct 2021
64
0
12
Nov 2021
40
0
24
Dec 2021
20
0
8
Jan 2022
41
0
6
Feb 2022
43
0
11
Mar 2022
45
0
8
Apr 2022
52
0
17
May 2022
69
0
16
Jun 2022
70
0
11
Jul 2022
68
0
6
Aug 2022
82
0
14
Sep 2022
102
0
19
Oct 2022
88
0
7
Nov 2022
111
0
19
Dec 2022
55
0
7
Jan 2023
55
0
9
Feb 2023
80
0
10
Mar 2023
97
0
11
Apr 2023
48
0
15
May 2023
74
0
12
Jun 2023
64
0
10
Jul 2023
58
0
6
Aug 2023
123
0
10
Sep 2023
279
0
18
Oct 2023
289
0
32
Nov 2023
194
0
16
Dec 2023
119
0
12
Jan 2024
40
0
5
Feb 2024
74
0
12
Mar 2024
106
0
15
Total
2650
0
378
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?